04:43 PM EDT, 03/28/2025 (MT Newswires) -- Connect Biopharma ( CNTB ) late Friday said it received a deficiency notice from the Nasdaq for its American depository shares trading below $1 minimum price threshold for more than 30 consecutive days.

Under Nasdaq rules, the company has 180 days after receiving the notification letter to resolve the deficiency. Connect said it plans to monitor the price of its ADSs and may consider potential remedies if it appears that it cannot return to compliance by the Sept. 22 deadline.